Alosa Health Resources: Cognitive Impairment and Alzheimer's Disease
Alosa Health has released a range of resources on cognitive impairment and Alzheimer's disease aimed at improving care for people with dementia and their caregivers, including information related to newly approved medications.
Dementia is a common condition in older adults, with over 6 million people being diagnosed with Alzheimer’s disease in the US. As many as 1 in 9 people over the age of 65 have Alzheimer’s disease, with that prevalence rising to 1 in every 3 people over the age of 85.
While many factors have been associated with the development of dementia, few interventions have conclusively proven to reduce dementia incidence - Alosa Health notes that two interventions that may reduce patient risk are controlling blood pressure and recommending a Mediterranean diet.
The resources cover a range of topics useful for clinicians and patients, including a review of newer medications, such as monoclonal antibodies that reduce amyloid deposits in the brain:
- Summary Brochure: Dealing with cognitive impairment - Evidence-based recommendations for prevention, diagnosis, and management
- Evidence Document: Dealing with cognitive impairment in older patients - Evidence-based recommendations for prevention, diagnosis, and management
- Patient Brochure – Advance care planning
- Patient Brochure – Amyloid
- Patient Brochure – BPSD
- Caregiver Resources
- Lecanemab (Leqembi) referral sheet
- Lecanemab (Leqembi) information for patients and families
- Lecanemab (Leqembi) information for clinicians
Additional resources for providers, for advance care planning, for driving, and for caregivers are listed, such as:
Go to the Alosa Health resources.
